C. Hennequin

1.2k total citations
72 papers, 711 citations indexed

About

C. Hennequin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, C. Hennequin has authored 72 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 25 papers in Surgery. Recurrent topics in C. Hennequin's work include Colorectal and Anal Carcinomas (10 papers), Breast Cancer Treatment Studies (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). C. Hennequin is often cited by papers focused on Colorectal and Anal Carcinomas (10 papers), Breast Cancer Treatment Studies (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). C. Hennequin collaborates with scholars based in France, United States and Switzerland. C. Hennequin's co-authors include Nicole Giocanti, Jacques Balosso, V Favaudon, D. Azria, L. Quéro, Pauline Brice, Jean‐Luc Donay, Emmanuel Raffoux, G. Socié and Nicolas Maziers and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

C. Hennequin

67 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Hennequin France 14 278 241 224 102 95 72 711
Catherine Devine United States 19 356 1.3× 229 1.0× 262 1.2× 213 2.1× 171 1.8× 53 1.1k
Carmen Rubio Spain 16 199 0.7× 231 1.0× 167 0.7× 23 0.2× 109 1.1× 72 666
Padraic O’Malley United States 15 277 1.0× 178 0.7× 616 2.8× 185 1.8× 72 0.8× 46 983
Paolo Magistri Italy 20 464 1.7× 444 1.8× 709 3.2× 73 0.7× 167 1.8× 101 1.2k
Spyridon P. Dourakis Greece 17 157 0.6× 123 0.5× 190 0.8× 78 0.8× 427 4.5× 60 1.1k
D. Elhardt United States 4 441 1.6× 325 1.3× 43 0.2× 66 0.6× 44 0.5× 8 700
Massimo Carlini Italy 20 496 1.8× 396 1.6× 627 2.8× 91 0.9× 69 0.7× 60 1.0k
Napoleone Prandini Italy 11 178 0.6× 91 0.4× 279 1.2× 19 0.2× 88 0.9× 37 553
Nicholas Vander United States 10 169 0.6× 149 0.6× 47 0.2× 62 0.6× 114 1.2× 13 507
Aufses Ah United States 16 194 0.7× 191 0.8× 369 1.6× 65 0.6× 174 1.8× 58 844

Countries citing papers authored by C. Hennequin

Since Specialization
Citations

This map shows the geographic impact of C. Hennequin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hennequin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hennequin more than expected).

Fields of papers citing papers by C. Hennequin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Hennequin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hennequin. The network helps show where C. Hennequin may publish in the future.

Co-authorship network of co-authors of C. Hennequin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Hennequin. A scholar is included among the top collaborators of C. Hennequin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Hennequin. C. Hennequin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hennequin, C., et al.. (2021). Role of radiotherapy for high risk localized prostate cancers. Cancer/Radiothérapie. 25(6-7). 660–662. 1 indexed citations
2.
Hennequin, C., D. Azria, Pierre Blanchard, et al.. (2021). Specificities of clinical research in radiotherapy. Cancer/Radiothérapie. 26(1-2). 104–107.
3.
Deutsch, Éric, C. Le Péchoux, Laurence Faivre, et al.. (2015). Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer. Annals of Oncology. 26(6). 1223–1229. 42 indexed citations
4.
Denis, Bruno, Matthieu Lafaurie, Jean‐Luc Donay, et al.. (2015). Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. International Journal of Infectious Diseases. 39. 1–6. 78 indexed citations
5.
Rozet, François, C. Bastide, Philippe Beuzeboc, et al.. (2014). Prise en charge des tumeurs de la prostate à faible risque évolutif. Progrès en Urologie. 25(1). 1–10. 7 indexed citations
6.
Hennequin, C., et al.. (2013). Mise au pointRadiobiologie de la curiethérapieRadiobiology in brachytherapy. Cancer/Radiothérapie. 17(2). 6 indexed citations
7.
Hennequin, C., L. Cormier, Pierre Richaud, et al.. (2013). Curiethérapie exclusive du cancer de la prostate par implants permanents : indications et résultats. Revue du CC-AFU. Progrès en Urologie. 23(6). 378–385. 11 indexed citations
8.
Hennequin, C. & J.J. Mazeron. (2013). Radiobiologie de la curiethérapie. Cancer/Radiothérapie. 17(2). 81–84. 12 indexed citations
9.
Thureau, S., Jean‐Emmanuel Bibault, J. Biau, et al.. (2013). Delegation of medical tasks in French radiation oncology departments: Current situation and impact on residents’ training. Cancer/Radiothérapie. 17(5-6). 370–377. 4 indexed citations
10.
Wong, C. Shun, C. Hennequin, & L. Quéro. (2013). Curiethérapie du cancer de l’œsophage. Cancer/Radiothérapie. 17(2). 159–161. 3 indexed citations
11.
Guitard, J., M. Develoux, Gabriel Carles, et al.. (2012). Commentez ce cas clinique. Journal de Mycologie Médicale. 22(2). 206–207.
12.
Doré, M. & C. Hennequin. (2012). Séquelles esthétiques de la radiothérapie adjuvante dans le traitement conservateur du cancer du sein localisé. Cancer/Radiothérapie. 16(5-6). 462–469. 10 indexed citations
13.
Rivera, Sofía, et al.. (2011). Cellules souches cancéreuses : nouvelle cible thérapeutique dans le traitement des cancers bronchopulmonaires. Cancer/Radiothérapie. 15(5). 355–364. 4 indexed citations
14.
15.
Quéro, L., C. Hennequin, & Pauline Brice. (2009). Place de la radiothérapie dans le traitement des lymphomes non hodgkiniens. Cancer/Radiothérapie. 13(6-7). 471–478. 6 indexed citations
16.
Azria, D., Yazid Belkacémi, Lagrange Jl, et al.. (2008). Séquelles radio-induites et tests prédictifs. Cancer/Radiothérapie. 12(6-7). 619–624. 10 indexed citations
17.
Hennequin, C., Nicole Giocanti, D. Averbeck, & Vincent Favaudon. (1999). La protéine kinase dépendante de l'ADN (DNA-PK), une enzyme clé de la religation des cassures double-brin de l'ADN. Cancer/Radiothérapie. 3(4). 289–295. 6 indexed citations
18.
Ravery, V., F Lamotte, C. Hennequin, et al.. (1998). Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1–T2 prostate cancer. Prostate Cancer and Prostatic Diseases. 1(6). 321–325. 9 indexed citations
19.
Resbeut, M. & C. Hennequin. (1994). Radiothérapie et chimiothérapie concomitance dans le traitement des cancers avancés du col utérin. 81(4). 437–445. 3 indexed citations
20.
Trédaniel, Jean, Pauline Brice, Éric Lepage, et al.. (1992). The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas. European Respiratory Journal. 5(2). 170–173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026